Continued Efficacy and Safety with up to 2 Years of Treatment with Lonapegsomatropin (TransCon hGH) in Children with Growth Hormone Deficiency
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI